Johnson & Johnson (JNJ) will begin trading ex-dividend on May 24, 2021. A cash dividend payment of $1.06 per share is scheduled to be paid on June 08, 2021. Shareholders who purchased JNJ prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 4.95% increase over prior dividend payment. At the current stock price of $171.07, the dividend yield is 2.48%.
The previous trading days last sale of JNJ was $171.07, representing a -1.49% decrease from the 52 week high of $173.65 and a 28% increase over the 52 week low of $133.65.
JNJ is a part of the Health Care sector, which includes companies such as Pfizer, Inc. (PFE) and Merck & Company, Inc. (MRK). JNJs current earnings per share, an indicator of a companys profitability, is $5.66. Zacks Investment Research reports JNJs forecasted earnings growth in 2021 as 18.53%, compared to an industry average of 10.3%.
Interested in gaining exposure to JNJ through an Exchange Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- SPDR Select Sector Fund - Health Care (XLV)
- iShares U.S. Healthcare ETF (IYH)
- First Trust Nasdaq Pharmaceuticals ETF (FTXH)
- iShares U.S. Pharmaceutical ETF (IHE)
- iShares U.S. ETF Trust (IEIH).
The top-performing ETF of this group is XLV with an increase of 11.55% over the last 100 days. It also has the highest percent weighting of JNJ at 9.7%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Find us at the office
Mcevilly- Liposky street no. 40, 55778 Tórshavn, Faroe Islands
Give us a ring
+23 188 845 957
Mon - Fri, 7:00-15:00